The role of the 5' untranslated region of eukaryotic messenger RNAs in translation and its investigation using antisense technologies.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Comparative analyses of the secondary structures of synthetic and intracellular yeast MFA2 mRNAs.Proceedings of the National Academy of Sciences of the United States of America · 1998
   Article
2. Maturation and translation mechanisms involved in the expression of a myb gene of rice.Plant molecular biology · 1997
   Article
3. Multiple steps in the regulation of transcription-factor level and activity.The Biochemical journal · 1996
   Review
4. Leishmania RNA virus 1-mediated cap-independent translation.Molecular and cellular biology · 1995
   Article
5. Target-specific arrest of mRNA translation by antisense 2'-O-alkyloligoribonucleotides.Nucleic acids research · 1994
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as